Ya Khamin Chan: Turmeric in Thai Traditional Medicine
Walk into an ordinary pharmacy in Bangkok, Chiang Mai or a provincial market town and you will find, somewhere near the antacids and the digestive tablets, a plastic bottle of bright yellow-orange capsules. The label reads ขมิ้นชัน — khamin chan — and it will tell you, in Thai, what the capsules are for: ท้องอืด ท้องเฟ้อ, bloating and flatulence. Nothing about joints. Nothing about inflammation, antioxidants or longevity. Just the upper gut, and wind.
This is turmeric as most of the world has actually used it, and it is the thread that explains why the two most important clinical trials of turmeric for digestion — in 1989 and in 2023 — were both run by Thai researchers. Thailand did not test turmeric for indigestion because a supplement company wanted a marketing claim. It tested turmeric for indigestion because turmeric for indigestion is what people there were already taking, in large numbers, and somebody decided to find out whether it worked.
Table of Contents
- The Name: Khamin Chan
- What Is Actually on the Shelf
- The Indication: Thong Uet, Thong Fao
- The Thai Herbal Houses
- Official Recognition — Stated Carefully
- Why Thailand Is a Serious Place for This Research
- The 2001 Peptic-Ulcer Study
- Turmeric in Thai Food and Household Remedies
- Whole Rhizome Versus Concentrated Extract
- Holding the Bottle: Dose, Quality and What to Check
- Key Research Papers
- Connections
- Featured Videos
The Name: Khamin Chan
ขมิ้นชัน — romanised khamin chan, sometimes written kamin chan or ka min chan — is the Thai name for Curcuma longa, the plant English speakers call turmeric. ขมิ้น (khamin) is the general word for a turmeric-type Curcuma; ชัน (chan) distinguishes this particular species from its relatives. The prefix ยา (ya) simply means "medicine", so ya khamin chan is "turmeric medicine" — the capsule rather than the spice.
The distinction matters more than it looks, because the Curcuma genus is large and Thailand uses several of its members for different purposes. Curcuma longa is the everyday culinary and medicinal turmeric. Other species in the same genus are used quite differently in Southeast Asian practice — Javanese turmeric (Curcuma xanthorrhiza) and black turmeric (Curcuma caesia) are separate plants with separate traditions, and a page about one is not a page about the others. Thai kitchens also use fingerroot (Boesenbergia rotunda), a related rhizome from the same family with its own digestive reputation.
When you see Curcuma domestica in older literature — including the 1989 trial — that is a synonym for Curcuma longa. Same plant, older name.
What Is Actually on the Shelf
Here is an honest description of the product, based on what such a bottle and its label state, without adding anything that cannot be read off it.
- The form is a capsule of dried, powdered rhizome. Not an extract. Not a standardised curcuminoid concentrate. Turmeric root, cleaned, dried, milled and encapsulated — effectively the spice in swallowable form. The powder is vividly yellow-orange and stains.
- Bottles of 100 capsules are the standard retail unit. Larger and smaller counts exist; 100 is what you will most often be handed.
- The capsule strength is printed in milligrams of powder. Because this is whole rhizome rather than extract, that milligram figure is not a curcuminoid figure. This is the single most misread number on the bottle, and we come back to it below.
- The indication is digestive. The Thai text on the label names wind, bloating and distension. The label does not present it as a joint or anti-inflammatory product.
- The dosing instruction is meal-anchored and multi-dose. Capsules taken with meals, several times a day — the same shape as the regimen the 1989 trial tested.
- It is cheap. This is an everyday pharmacy commodity in Thailand, not a premium wellness product, and it is priced accordingly.
That last point carries more weight than it might seem. A remedy that stays on pharmacy shelves for decades at a low price, without a marketing machine behind it, is a remedy people keep buying because they think it works for them. That is not evidence in the clinical sense. It is a reason to run a trial — which is exactly what happened.
The Indication: Thong Uet, Thong Fao
ท้องอืด ท้องเฟ้อ — thong uet, thong fao — is the phrase to know. ท้อง (thong) is the abdomen or belly. อืด (uet) means distended, swollen, tight. เฟ้อ (fao) carries the sense of gassy, windy, over-full. Together they describe, with considerable precision, the complaint that Western medicine files under postprandial distress: the belly that feels blown up and heavy after eating.
It is worth pausing on how well that traditional phrase maps onto the modern diagnostic category. The Rome criteria's postprandial distress syndrome — bothersome fullness after ordinary meals, early satiety, with bloating and belching clustering alongside — is essentially a formalisation of thong uet, thong fao. The traditional indication was not vague. It named a specific symptom cluster, tied it to meals, and prescribed a meal-timed remedy for it.
That alignment is why the Thai trials are so useful. When Thamlikitkul's group ran the 1989 study, they were not inventing an indication to test. They were taking the indication the label already claimed and subjecting it to a randomised, double-blind comparison against placebo and against an anti-flatulence preparation, which the abstract calls simply "flatulence". The trial enrolled 116 adults with acid, flatulent or atonic dyspepsia in one provincial and 5 community hospitals. Fifty-three per cent of patients on placebo responded, against 83 per cent on the anti-flatulence comparator and 87 per cent on turmeric; the differences between placebo and the active drugs were statistically significant, and mild, self-limited side effects occurred at similar rates in all three groups. And when Kongkam's group at Chulalongkorn ran the 2023 trial, they tested the same traditional indication against omeprazole, the modern standard drug — in patients formally diagnosed with functional dyspepsia. The full account of both trials is in Turmeric for Functional Dyspepsia and Bloating.
The Thai Herbal Houses
Thai turmeric capsules are made by a number of domestic manufacturers. Some are long-established Thai herbal-medicine houses whose business is traditional Thai and Chinese herbal preparations manufactured at pharmaceutical scale, sold through ordinary pharmacies rather than through health-food channels.
The wider point is about the category, not any one firm. Thailand has a domestic herbal-medicine manufacturing sector that is old, regulated as medicine rather than as food, and entirely mainstream. Herbal preparations there are not a fringe alternative to pharmacy; they are stocked in the pharmacy, dispensed by pharmacists, and in many hospitals prescribed by doctors alongside conventional drugs. Thai traditional medicine is taught, licensed and practised as a recognised profession.
For a reader used to the Western supplement market — where botanicals are regulated as food, manufacturers make no medical claims, and quality varies enormously — this is a genuinely different regulatory world, and it changes what a bottle of turmeric capsules is. It is a licensed medicinal product with a stated indication, not a food supplement with a disclaimer.
Official Recognition — Stated Carefully
This section is deliberately conservative, because the internet is full of confident, unsourced claims about exactly which Thai list turmeric appears on, in which category, and since which year. We are not going to add to them.
What can be said accurately:
- Turmeric capsules are widely used in Thailand for dyspeptic symptoms — bloating, distension and wind — and are sold for that purpose through ordinary pharmacies.
- Turmeric holds official recognition within the Thai system as a herbal medicine for that indication, rather than existing only as an informal folk remedy. Herbal preparations in Thailand are regulated as medicinal products, and turmeric is among the traditional herbs formally incorporated into the national system.
- Thai researchers ran both of the key clinical trials — Thamlikitkul and colleagues in 1989, and Kongkam and colleagues in 2023. Both were randomised and double-blind. Both were led from Thailand. This is the real and interesting point, and it needs no embellishment.
What we are not going to state: a specific listing year, a specific category within the Thai National List of Essential Medicines, an approval number, or any other regulatory particular that we cannot source directly. Those details may well exist; this page does not assert what it cannot verify. For the current regulatory status, the Thai Food and Drug Administration and the Department of Thai Traditional and Alternative Medicine are the authorities, and their current documents are the only acceptable source.
What the recognition means in practice is simpler than the paperwork: in Thailand, turmeric for indigestion is not an alternative to medicine. It is medicine — cheap, ordinary, and on the shelf.
Why Thailand Is a Serious Place for This Research
It would be easy to read "Thai study" as a warning label. The record points the other way, for these reasons.
The research question came from practice, not from marketing
Most botanical trials in the West begin with a product looking for a claim. The Thai turmeric trials began with a widely used traditional remedy and asked whether it worked. That is the direction of inquiry that produces useful answers, including negative ones.
The trials used the right comparators
The 1989 study compared turmeric against placebo and against an active anti-flatulence preparation (named "flatulence" in the abstract). The 2023 study compared curcumin against omeprazole — not against nothing, not against a weaker herbal, but against one of the most prescribed drugs in the world, in a double-blind, double-dummy design. Choosing a comparator you might lose to is what distinguishes a real question from a promotional exercise.
The 2023 trial's numbers: 206 patients with functional dyspepsia were randomly assigned to curcumin alone, omeprazole alone, or curcumin plus omeprazole, and 151 completed the study. The curcumin dose was two capsules of 250 mg curcumin, four times daily, and the omeprazole dose one 20 mg capsule once daily, for 28 days. Symptom scores on the Severity of Dyspepsia Assessment (SODA) improved significantly in all three groups by day 28 and improved further by day 56. "No significant differences were observed among the three groups", and no serious adverse events occurred. The authors concluded that curcumin and omeprazole had "comparable efficacy for functional dyspepsia with no obvious synergistic effect".
The institutions are substantial
The 2023 trial came out of Chulalongkorn, one of Thailand's major medical research centres, and was published in BMJ Evidence-Based Medicine — a mainstream international journal with no particular sympathy for herbal medicine. The earlier work appeared in the Journal of the Medical Association of Thailand, the country's principal general medical journal.
The plant grows there
A practical point that is easy to miss: Thailand is a major turmeric-growing country with a domestic manufacturing sector, so researchers there have access to well-characterised local material, and the product they test is the product people actually buy. That is a closer link between trial and practice than most supplement research achieves.
And the record includes failures
Thai turmeric research also includes studies that were uncontrolled and therefore weak — the 2001 peptic-ulcer study below is one. Reporting those honestly is part of why the stronger trials deserve to be believed.
What the reviews found
Two systematic reviews have since pooled this work with trials from elsewhere.
- Cochrane, 2023. A Cochrane review of non-Chinese herbal medicines for functional dyspepsia included 41 trials with 4477 participants, covering 27 herbal medicines. It found that Curcuma longa "probably results in a moderate improvement" in global symptoms of dyspepsia compared with placebo at four weeks (MD -3.33, 95% CI -5.84 to -0.81; 2 studies, 110 participants; moderate certainty), with "probably little to no difference" in the rate of adverse events. Compared with other treatments, Curcuma longa "may provide little to no benefit". In the same review, fingerroot (Boesenbergia rotunda) may also improve dyspepsia symptoms compared with placebo, based on one study of 160 participants (low certainty).
- 2024 systematic review. A 2024 review covered 26 studies of turmeric for digestive disorders — inflammatory bowel disease, irritable bowel syndrome, dyspepsia, reflux (gastroesophageal reflux disease) and peptic ulcer. "Most studies were assessed to have a high risk of bias", and the studies were too different to pool. Turmeric appeared safe, with possible benefit in inflammatory bowel disease and irritable bowel syndrome, but "its effects were inconsistent for other conditions", and the authors concluded that its efficacy in digestive disorders "remains unclear".
The 2001 Peptic-Ulcer Study
Prucksunand and colleagues published a phase II clinical trial in the Southeast Asian Journal of Tropical Medicine and Public Health in 2001, examining the effect of long turmeric (Curcuma longa Linn) on the healing of peptic ulcer. It is frequently cited as evidence that turmeric heals ulcers. That citation needs a qualification attached to it every single time, so here it is.
The study had no control group. It was an open, uncontrolled phase II trial: patients with endoscopically confirmed ulcers were given turmeric capsules and re-scoped later, and healing was reported. Ulcers were seen to heal.
What the study reported: 45 patients with symptoms of peptic ulcer took part, and 25 of them had ulcers confirmed by endoscopy, 0.5 to 1.5 cm across, in the duodenal bulb or the stomach. They took 2 capsules (300 mg each) of turmeric five times daily. Ulcers were absent in 48% (12 cases) after 4 weeks, in 18 cases after 8 weeks, and in 19 cases (76%) after 12 weeks. Blood tests showed no significant changes in liver or kidney function before and after treatment.
Why that proves much less than it appears to:
- Peptic ulcers heal on their own. A meaningful proportion of ulcers heal with time, dietary change, and removal of whatever provoked them. Without a control arm, there is no way to separate turmeric's contribution from natural history.
- No blinding. Everyone knew what was being given, including the endoscopists assessing healing.
- No comparator. Ulcer therapy in 2001 already included effective acid suppression and, where H. pylori was present, eradication regimens. The study does not tell you how turmeric compares with either.
- Phase II means exploratory. The purpose of a phase II study is to decide whether a larger controlled trial is worth running. It is a signal to investigate, not a result to act on.
The appropriate conclusion is that the study justified further research on turmeric and gastric mucosal healing — research that has since been done mostly in rats, and which we cover on the gut inflammation article. It does not support telling anyone with an ulcer to take turmeric instead of treatment. A peptic ulcer is a diagnosis that needs proper management, including testing for H. pylori.
Turmeric in Thai Food and Household Remedies
Long before the capsule, there was the kitchen. Turmeric's culinary use in Thailand is regional and specific, and it is heaviest in the south.
- Southern Thai cooking uses turmeric generously — it is a defining note of the region's curries and of dishes built on fresh rhizome pounded into a paste with garlic, pepper, chilli and shrimp paste. Southern yellow curry owes its colour and much of its character to fresh turmeric.
- Fried chicken and fish marinated with turmeric, garlic and pepper is a southern staple — the turmeric is a marinade ingredient, not a garnish.
- Fresh rhizome, not just powder. Thai markets sell fresh turmeric root alongside galangal, ginger and fingerroot. Fresh rhizome is used sliced, pounded or juiced, and behaves differently in a dish from dried powder.
- The household preparation for stomach complaints has traditionally been simple: fresh turmeric pounded and taken with warm water, or dried powder stirred into water or honey, taken around meals.
Two things follow from this that are easy to miss when turmeric arrives in a capsule.
First, turmeric is nearly always eaten with fat in Thai cooking — coconut milk, oil, the fat in the meat or fish. Curcuminoids are fat-soluble, and the culinary tradition delivers them in exactly the medium that helps. It also delivers them alongside a fatty meal, which is precisely the stimulus that triggers gallbladder contraction, the mechanism explored in Turmeric, Bile and Fat Digestion.
Second, turmeric almost never travels alone. It arrives with black pepper, with garlic, with galangal, with fingerroot — a whole aromatic complex, several members of which have digestive reputations of their own. Black pepper is the interesting case: piperine, its principal alkaloid, is the compound shown in 1998 to raise curcumin's bioavailability enormously in humans and animals. Southeast Asian cooking combined the two for centuries before anyone knew why that combination might matter.
Whole Rhizome Versus Concentrated Extract
The most practical point in this article is this. A Thai turmeric capsule and a Western curcumin capsule are not the same product, and treating them as interchangeable leads people to badly wrong conclusions about dose.
The whole-rhizome capsule
Dried, powdered Curcuma longa root. Curcuminoids make up only a small percentage of dried turmeric rhizome by weight — commonly cited in the low single digits, varying with cultivar, growing conditions and processing. The rest is starch, fibre, protein, minerals, and the volatile oil fraction dominated by turmerones, which give turmeric its smell and are not pharmacologically inert.
This is what Thai pharmacies sell. It is what the 1989 trial tested. It is, in effect, the spice.
The standardised curcumin extract
Solvent-extracted and concentrated, typically to around 95% curcuminoids, with most of the starch, fibre and volatile oils removed. Often combined with piperine or formulated as a phospholipid complex or nanoparticle to raise blood levels. This is what the great majority of Western supplements contain and what most modern trials — including the arthritis literature — use.
The arithmetic, and why it trips people
A capsule of concentrated extract can carry twenty to thirty times the curcuminoid content of the same weight of dried rhizome. So "500 mg of turmeric" and "500 mg of curcumin extract" describe products that differ by more than an order of magnitude in the compound everyone is talking about. Somebody who reads that a trial used a large daily milligram figure of extract, and then takes that many milligrams of rhizome powder, is taking a small fraction of the studied dose. Somebody who does the reverse is taking a great deal more than they think.
How the Two Compare for Digestion
Genuinely unknown — no trial has compared them head to head for this indication. But the question is less lopsided than it first appears, for the reason set out in the leg overview: if the target tissue is the gut lining itself, then absorption is not the objective, and the whole-rhizome capsule with its fibre, starch and volatile oils has a real case rather than merely a traditional one. Lopresti's 2018 review is the paper that makes this argument properly.
Holding the Bottle: Dose, Quality and What to Check
For a bottle brought home from Thailand or bought online, these are the points the label and the research cover.
On dose
- The milligram figure is rhizome powder, not curcuminoid, unless the label explicitly says extract or gives a curcuminoid percentage.
- The label's schedule is meal-timed. The traditional and trialled pattern is several modest doses a day, with meals — not one large dose. The 1989 protocol was two capsules four times daily for seven days.
- The traditional use is a short course. The traditional use is for a bout of symptoms, not as a daily supplement taken indefinitely. The 1989 trial gave 7 days of treatment and the 2023 trial 28 days, with symptoms checked again at day 56.
- When change was measured. The 1989 trial assessed response after its 7 days of treatment; in the 2023 trial, symptom scores had improved by day 28 and improved further by day 56.
On quality
- Heavy metals are the real concern with turmeric, and it is not hypothetical. Lead chromate has been used as an adulterant to brighten turmeric's colour in some producing regions — a documented food-safety problem, not a rumour. In Bangladesh, the share of market turmeric samples with detectable lead was 47% in 2019 and fell to 0% by 2021 after a campaign of news coverage, education and enforcement.
- A labelled product carries a manufacturer, a batch number and an expiry date printed on it. In Thailand, a licensed herbal medicine carries registration details; a bag of loose powder from a market stall carries nothing.
- Colour is not a quality signal. Brighter is not better, and in the adulteration cases, brighter was the whole point of the adulterant.
- Storage matters. Curcuminoids degrade with light and heat, so a dark bottle in a cupboard keeps them better than a windowsill.
On safety
Turmeric at culinary and traditional doses has a long, reassuring record. That record is about the spice and modest rhizome doses; the concerns that have emerged in recent years attach mainly to high-dose concentrated extracts. Three specifics stand out:
- Gallstones. Turmeric makes the gallbladder contract: in a crossover study of 12 healthy volunteers, 20 mg of curcumin reduced gallbladder volume by 29.3% at 2 hours. Known gallstones and a past blocked bile duct are the situations in which the research raises a concern about turmeric supplements.
- Liver injury. A US Drug-Induced Liver Injury Network case series described ten patients with liver injury associated with turmeric supplements — rare, but real, and linked to concentrated products.
- Oxalate. Turmeric increased urinary oxalate excretion in healthy volunteers in a controlled study, a finding that matters most for people who form calcium-oxalate kidney stones.
The fuller picture, including drug interactions, is in the Turmeric Safety and Interactions leg.
Key Research Papers
- Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, et al. (1989). Randomized double blind study of Curcuma domestica Val. for dyspepsia. Journal of the Medical Association of Thailand. — PubMed PMID: 2699615 (the landmark Thai trial)
- Kongkam P, Khongkha W, Lopimpisuth C, et al. (2023). Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial. BMJ Evidence-Based Medicine. — PubMed PMID: 37696679 (Thai three-arm trial against omeprazole)
- Prucksunand C, Indrasukhsri B, Leethochawalit M, et al. (2001). Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian Journal of Tropical Medicine and Public Health. — PubMed PMID: 11485087 (Thai study; uncontrolled, no comparison group)
- Lopresti AL (2018). The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Advances in Nutrition. — PubMed PMID: 29438458
- Shoba G, Joy D, Joseph T, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. — PubMed PMID: 9619120
- Chainani-Wu N (2003). Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). Journal of Alternative and Complementary Medicine. — PubMed PMID: 12676044
- Gupta SC, Patchva S, Aggarwal BB (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. — PubMed PMID: 23143785
- Kwiecien S, Magierowski M, Majka J, et al. (2019). Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. International Journal of Molecular Sciences. — PubMed PMID: 30909623
- Halegoua-DeMarzio D, Navarro V, Ahmad J, et al. (2023). Liver Injury Associated with Turmeric — A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. American Journal of Medicine. — PubMed PMID: 36252717
- Tang M, Larson-Meyer DE, Liebman M (2008). Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. American Journal of Clinical Nutrition. — PubMed PMID: 18469248
- Báez G, Vargas C, Arancibia M, Papuzinski C, Franco JV (2023). Non-Chinese herbal medicines for functional dyspepsia. Cochrane Database of Systematic Reviews. — PubMed PMID: 37323050
- Thavorn K, Wolfe D, Faust L, Shorr R, Akkawi M, Isaranuwatchai W, Klinger C, Chai-Adisaksopa C, Tanvejsilp P, Nochaiwong S, Straus SE, Hutton B (2024). A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders. Phytotherapy Research. — PubMed PMID: 38503513
- Rasyid A, Lelo A (1999). The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Alimentary Pharmacology & Therapeutics. — PubMed PMID: 10102956
- Forsyth JE, Baker M, Nurunnahar S, et al. (2023). Food safety policy enforcement and associated actions reduce lead chromate adulteration in turmeric across Bangladesh. Environmental Research. — PubMed PMID: 37286126
PubMed Topic Searches
Connections
- Turmeric for Digestive Health
- Turmeric for Functional Dyspepsia and Bloating
- Turmeric, Bile and Fat Digestion
- Turmeric for Irritable Bowel Syndrome, Gut Inflammation and H. pylori
- Turmeric
- History of Turmeric
- Turmeric Safety and Interactions
- Turmeric Bioavailability and Forms
- Javanese Turmeric
- Black Turmeric
- Fingerroot
- Thai Basil
- Kaffir Lime
- Black Ginger
- Gut Health
- Culinary and Spice Herbs